Representations regarding the efficacy and safety of Derma ProGenix have not been evaluated by the Food and Drug Administration. The FDA only evaluates foods and drugs, not supplements like these products. These products are not intended to diagnose, prevent, treat, or cure any disease. Click here to find evidence of a test, analysis, research, or study describing the benefits, performance or efficacy of Derma ProGenix based on the expertise of relevant professionals. Comparison data from clinical study dated March 2006 on the benefits of Matrixyl™3000, a brand owned by Sederma. Matrixyl™3000 is a brand for Palmitoyl Oligopeptide and Palmitoyl Tetrapeptide-7, which are the effective ingredients in Derma ProGenix, see Case Study for study summary.